| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Center for Vaccines and Immunity, Columbus Children’s Research Institute, Columbus, OH, 43205;
La Jolla Institute for Allergy and Immunology, San Diego, CA 92121; and
College of Medicine and Public Health, Ohio State University, Columbus, OH 43205
Control of hepatitis C virus (HCV) infection could be influenced by the timing and magnitude of CD4+ T cell responses against individual epitopes. We characterized CD4+ T cells targeting seven Pan troglodytes (Patr) class II-restricted epitopes during primary and secondary HCV infections of a chimpanzee. All Patr-DR-restricted HCV epitopes bound multiple human HLA-DR molecules, indicating the potential for overlap in epitopes targeted by both species. Some human MHC class II molecules efficiently stimulated IL-2 production by chimpanzee virus-specific T cell clones. Moreover, one conserved epitope designated NS31248 (GYKVLVLNPSV) overlapped a helper epitope that is presented by multiple HLA-DR molecules in humans who spontaneously resolved HCV infection. Resolution of primary infection in the chimpanzee was associated with an initial wave of CD4+ T cells targeting a limited set of dominant epitopes including NS31248. A second wave of low-frequency CD4+ T cells targeting other subdominant epitopes appeared in blood several weeks later after virus replication was mostly contained. During a second infection 7 years later, CD4+ T cells against all epitopes appeared in blood sooner and at higher frequencies but the pattern of dominance was conserved. In summary, primary HCV infection in this individual was characterized by T cell populations targeting two groups of MHC class II-restricted epitopes that differed in frequency and kinetics of appearance in blood. The hierarchial nature of the CD4+ T cell response, if broadly applicable to other HCV-infected chimpanzees and humans, could be a factor governing the outcome of HCV infection.
This article has been cited by other articles:
|
|
 |
|
  R. K. Ramalingam, D. Meyer-Olson, N. H. Shoukry, D. G. Bowen, C. M. Walker, and S. A. Kalams Kinetic Analysis by Real-Time PCR of Hepatitis C Virus (HCV)-Specific T Cells in Peripheral Blood and Liver after Challenge with HCV J. Virol., November 1, 2008; 82(21): 10487 - 10492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lin, T. Kwon, J. Polo, Y.-F. Zhu, S. Coates, K. Crawford, C. Dong, M. Wininger, J. Hall, M. Selby, et al. Induction of Broad CD4+ and CD8+ T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5 J. Virol., August 1, 2008; 82(15): 7492 - 7503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, D. K. Krishnadas, R. Kumar, D. L. J. Tyrrell, and B. Agrawal Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine Int. Immunol., January 1, 2008; 20(1): 89 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Price, A. D. Bitmansour, J. B. Edgar, J. M. Walker, M. K. Axthelm, D. C. Douek, and L. J. Picker Induction and Evolution of Cytomegalovirus-Specific CD4+ T Cell Clonotypes in Rhesus Macaques J. Immunol., January 1, 2008; 180(1): 269 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Schulze zur Wiesch, G. M. Lauer, J. Timm, T. Kuntzen, M. Neukamm, A. Berical, A. M. Jones, B. E. Nolan, S. A. Longworth, V. Kasprowicz, et al. Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection Blood, September 1, 2007; 110(5): 1559 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, D. K. Krishnadas, J. Li, D. L. J. Tyrrell, and B. Agrawal Induction of Primary Human T Cell Responses against Hepatitis C Virus-Derived Antigens NS3 or Core by Autologous Dendritic Cells Expressing Hepatitis C Virus Antigens: Potential for Vaccine and Immunotherapy J. Immunol., May 15, 2006; 176(10): 6065 - 6075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schulze zur Wiesch, G. M. Lauer, C. L. Day, A. Y. Kim, K. Ouchi, J. E. Duncan, A. G. Wurcel, J. Timm, A. M. Jones, B. Mothe, et al. Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes J. Immunol., September 15, 2005; 175(6): 3603 - 3613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari Robust hepatitis C virus infection in vitro PNAS, June 28, 2005; 102(26): 9294 - 9299. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
